I now have sufficient information to provide a comprehensive clinical response. Let me compile the full management plan for this complex geriatric case.
Clinical Assessment and Management
Rapid Differential Diagnosis - This is NOT a Simple Recurrent Stroke
This 95-year-old female presents with a highly atypical pattern that demands careful analysis before assuming "another stroke." The combination of:
- Bilateral limb weakness (not unilateral)
- Headache for 1 day
- Known aspirin use (antiplatelet therapy)
- Age 95 with prior stroke + cerebral atrophy
- Plantar responses DOWN-GOING (indicating UMN pattern, but bilateral)
...raises a critical differential that must be prioritized before assuming ischemic stroke.
Step 1: Immediate Stabilization (Emergency)
ABC + Vitals
- Secure airway, administer O2 (target SpO2 92-96% in COPD - avoid over-oxygenation)
- IV access, cardiac monitoring, pulse oximetry
- Check blood glucose immediately (hypoglycemia mimics stroke)
- BP measurement (both arms)
- 12-lead ECG (AF? new arrhythmia?)
- Temperature (infection?)
Urgent Bloods:
- CBC (thrombocytopenia on aspirin?)
- Coagulation screen (PT/INR, APTT)
- BMP/electrolytes (sodium, glucose, calcium, renal function)
- TSH (hypothyroid crisis causing neurological symptoms?)
- ABG if COPD concern
- Troponin
Step 2: Urgent Imaging - CRITICAL PRIORITY
Non-Contrast CT Head - STAT
This is the most important immediate investigation. Key differentials to exclude:
TOP DIFFERENTIAL: Chronic Subdural Hematoma (CSDH)
This patient is at very high risk for CSDH based on:
- Age 95 - significant cerebral atrophy (bridging veins stretched and vulnerable)
- Long-term aspirin use - impairs hemostasis, promotes venous ooze
- Bilateral involvement (CSDH is bilateral in ~20% of patients)
- Headache + bilateral limb weakness is a classic CSDH presentation
- No mention of trauma needed - minor or no trauma can cause CSDH in the elderly
As per Plum and Posner's Diagnosis and Treatment of Stupor and Coma: "Chronic subdural hematomas usually occur in elderly patients or those on anticoagulants... A history of trauma can be elicited in only about one-half of patients, and then the trauma is usually minor." The bilateral pattern occurs in ~20% of cases.
The same text notes: "A useful rule when faced with a comatose or neurologically impaired patient is that 'it could always be a subdural,' and hence imaging is needed even in cases where focal signs are absent."
Other Differentials on CT Head:
| Diagnosis | Key Clues |
|---|
| Chronic subdural hematoma (bilateral) | Age, aspirin, cerebral atrophy, bilateral signs |
| Intracerebral hemorrhage | Sudden onset, HTN history |
| New ischemic stroke (bilateral = basilar or bilateral hemisphere) | Rule out by imaging |
| Subdural hygroma | Similar presentation to CSDH |
| Cerebral venous sinus thrombosis | Headache + bilateral signs, dehydration in elderly |
| Metabolic encephalopathy | Bilateral signs, no focal imaging changes |
| Hypertensive emergency (PRES) | HTN + bilateral weakness + headache |
If CT is non-diagnostic or CSDH suspected but CT equivocal:
- MRI brain with FLAIR/DWI - superior for CSDH dating, small infarcts, posterior fossa lesions, venous thrombosis
Step 3: Aspirin - HOLD Pending Imaging
Do NOT give additional antithrombotic loading until hemorrhage is excluded. The patient is already on aspirin - this drug may in fact be contributing to CSDH expansion. Hold aspirin until CT result is reviewed.
Do NOT give IV tPA until:
- Hemorrhage is excluded
- Exact diagnosis is established
- Time window is confirmed
- Age/benefit assessment completed (95 years - high bleeding risk)
Step 4: Diagnosis-Specific Management
If CSDH confirmed:
Neurosurgical referral immediately
Management options per textbook evidence (Plum & Posner):
- Burr hole drainage / craniotomy - for symptomatic CSDH causing neurological deficit (standard of care)
- Hold aspirin perioperatively
- Corticosteroids (dexamethasone) - some evidence supports this as an adjunct or alternative in patients unfit for surgery; recent meta-analyses show no superiority of surgery over steroids in selected low-risk cases
- Consider patient's frailty, comorbidities, and goals of care at age 95
If Acute Ischemic Stroke confirmed (no hemorrhage):
IV tPA (alteplase) consideration:
- Age 95 is not an absolute contraindication, but risk-benefit must be weighed carefully
- Window: within 4.5 hours of symptom onset
- NIHSS score assessment required
- Bilateral hemiplegia suggests basilar territory or bilateral hemisphere involvement - may need CT angiography to look for basilar artery occlusion
- Pre-existing aspirin use is noted; does not preclude thrombolysis
- The Washington Manual notes: "Thrombolytic therapy should not be delayed while waiting for PT/PTT/platelet unless bleeding abnormality suspected or patient has been taking warfarin, heparin, dabigatran, rivaroxaban, or apixaban" - since she is only on aspirin, this is less of a concern
BP management in acute ischemic stroke:
- Per Family Medicine Textbook: "During the first day after an ischemic stroke, most patients with elevated blood pressure should not be treated unless SBP is consistently >220 mmHg or DBP consistently >120 mmHg"
- Exception: if tPA is being administered, target BP <185/110 before and <180/105 after
Endovascular thrombectomy:
- Consider if large vessel occlusion on CTA (basilar, MCA, ICA)
- Window up to 24 hours in selected patients
- Core infarct volume ≤20 mL if age ≥80 years
If Intracerebral Hemorrhage:
- Stop aspirin immediately
- Neurosurgical consult
- BP target: SBP <140 mmHg
- Reversal of antiplatelet effect: consider platelet transfusion if surgical intervention planned
If Cerebral Venous Sinus Thrombosis:
- Anticoagulation (LMWH or IV heparin) even if hemorrhagic infarct present
- Hydration
Step 5: Comorbidity-Specific Management
COPD
- O2 target SpO2 88-92% (controlled oxygen therapy; avoid respiratory drive suppression)
- Continue bronchodilators
- Avoid over-sedation
Hypothyroidism
- Check TSH - myxedema can mimic and worsen neurological outcomes
- Ensure thyroxine is continued
- Myxedema coma is rare but can present with altered mentation and bilateral weakness
Hypertension
- Context-dependent BP management (see above)
- Avoid aggressive lowering in acute ischemic stroke
Age 95 - Frailty Considerations
- Early discussion with family/surrogate regarding goals of care and resuscitation status
- Frailty assessment (Clinical Frailty Scale)
- Multi-disciplinary team: neurology, neurosurgery, geriatrics, physiotherapy
Step 6: Secondary Prevention Review
Once acute phase is stabilized:
Per Goldman-Cecil Medicine: antiplatelet therapy is a first-line agent for secondary stroke prevention. The Family Medicine Textbook notes: "Both extended-release dipyridamole plus aspirin (Aggrenox) and clopidogrel are reasonable first-line antiplatelet agents for secondary stroke prevention, shown to be more effective than aspirin alone."
- If ischemic stroke: consider switching from aspirin alone to aspirin + dipyridamole or clopidogrel monotherapy
- If AF discovered on ECG: anticoagulation (DOAC preferred over warfarin in elderly, subject to bleeding risk assessment; PMID 39921198 meta-analysis supports DOACs over aspirin for embolic stroke)
- If CSDH: antiplatelet therapy should be restarted cautiously post-drainage, typically after 4-6 weeks
Summary Checklist
| Priority | Action |
|---|
| 1 | Stabilize ABC, check glucose, ECG, vitals |
| 2 | STAT non-contrast CT head |
| 3 | Hold aspirin until hemorrhage excluded |
| 4 | Labs: CBC, coag, electrolytes, TSH, ABG |
| 5 | Controlled O2 for COPD (88-92%) |
| 6 | Call neurosurgery if CSDH/ICH found |
| 7 | Thrombolysis/thrombectomy if ischemic and eligible |
| 8 | Goals of care discussion given age 95 |
| 9 | Neurology + geriatrics consult |
| 10 | Physiotherapy, dysphagia screen, DVT prophylaxis |
Key Teaching Point: In a 95-year-old on aspirin with bilateral headache and weakness, chronic bilateral subdural hematoma must be excluded first before assuming recurrent stroke. The clinical picture does not fit a classic unilateral hemispheric stroke, and this patient has multiple risk factors for CSDH. The CT head result is the pivot point for all further management decisions.
- Plum and Posner's Diagnosis and Treatment of Stupor and Coma, pp. 248-254
- Textbook of Family Medicine 9e, pp. 1220-1226
- The Washington Manual of Medical Therapeutics, pp. 1019-1022